Uncategorised - European Medical Journal

Warning Issued as Scabies Cases Surge Across England

The Royal College of General Practitioners (RCGP) has reported a significant rise in scabies cases presenting at GP surgeries across England…

How Chronic Stress Worsens Heart Attack Damage

The pathophysiological effects of chronic psychological stress on acute myocardial infarction (AMI) using a rat model, uncovering dynamic impacts on heart health that could inform treatment protocols, have been published in a new study.

Long-Term Effects of Recurrent Rejection on Paediatric Heart Transplant Outcomes

Analysis of recurrent rejection (RR) in paediatric heart transplant recipients revealed that 17% of the population studied experienced RR.

24-Hour Antibiotic Course Prevents Infection Post-Cystectomy

A recent single-centre, randomised, trial has explored the effects of a 24-hour perioperative antibiotic course for patients undergoing cystectomy.

Air Pollution's Role in Rising Global Asthma Cases

Recent studies and meta-analyses have investigated the impact of PM2.5 on asthma, yet findings remain inconsistent.

AI Model Matches Radiologists in Detecting Chest X-Ray Abnormalities

A commercially available AI model has been found to perform on par with radiologists in detecting chest X-ray abnormalities.

Semaglutide Reduces Risk of Alzheimer’s Disease

Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in people with Type 2 diabetes (T2D).

5 stars

Boehringer, Amgen and Novartis rank top for cardiovascular patient groups

Boehringer Ingelheim, Amgen and Novartis have been awarded the highest reputation scores by several cardiovascular patient advocacy groups.

Sustainable pharma packaging takes a big step forward

UPM Biochemicals, Selenis and Bormioli Pharma have introduced the pharmaceutical industry’s first bottle made with wood-based PET.

Promising Results for CAR T-Cell Therapy in Relapsed T-Cell Acute Lymphoblastic Leukaemia

A breakthrough study has reported encouraging outcomes using autologous chimeric antigen receptor T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukaemia.